ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 361,000
-15,500 (-4.12%)
At close: Feb 6, 2026
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 19.31 trillion as of February 6, 2026. Its market cap has increased by 17.05% in one year.
Market Cap
19.31T
Enterprise Value
19.06T
Revenue
202.18B
Ranking
n/a
PE Ratio
159.53
Stock Price
361,000.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 19.31T, an increase of 15,995.14%. That is a compound annual growth rate of 57.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 19.31T | -19.69% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.69T |
| Celltrion | 47.59T |
| SK Biopharmaceuticals | 8.73T |
| HLB Co., Ltd. | 6.95T |
| LigaChem Biosciences | 6.63T |
| Peptron | 6.39T |
| Voronoi | 3.93T |
| SK bioscience | 3.82T |